LAXACIN is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Direct Rx. The primary component is Docusate Sodium; Sennosides A And B.
Product ID | 61919-497_838584ec-1cff-b130-e053-2a91aa0a70a1 |
NDC | 61919-497 |
Product Type | Human Otc Drug |
Proprietary Name | LAXACIN |
Generic Name | Laxacin |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-03-26 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Labeler Name | DIRECT RX |
Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B |
Active Ingredient Strength | 50 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-03-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-08-28 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-03-26 |
Ingredient | Strength |
---|---|
DOCUSATE SODIUM | 50 mg/1 |
SPL SET ID: | 68526336-76bb-7eac-e053-2a91aa0a751e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
45865-708 | Laxacin | Docusate sodium and sennosides |
50488-0901 | Laxacin | Docusate sodium and sennosides |
55700-930 | Laxacin | Docusate sodium and sennosides |
61919-497 | LAXACIN | LAXACIN |
68071-1549 | Laxacin | Docusate sodium and sennosides |
68258-4985 | Laxacin | Docusate sodium and sennosides |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LAXACIN 86119347 4555933 Live/Registered |
Alexso, Inc. 2013-11-14 |